Binda E et al. confirmed that Wnt5a could improve the invasion of glioma cells, and knocking down Wnt5a inhibited the intracranial invasion of glioma and increase the survival rate of mice (Binda et al. 2017). This evidence concerns the gene WNT5A and central nervous system cancer.